Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biofrontera (BFRI) Short term Debt (2021 - 2024)

Historic Short term Debt for Biofrontera (BFRI) over the last 4 years, with Q2 2024 value amounting to $296000.0.

  • Biofrontera's Short term Debt changed N/A to $296000.0 in Q2 2024 from the same period last year, while for Jun 2024 it was $296000.0, marking a year-over-year change of. This contributed to the annual value of $3.9 million for FY2023, which is 4376.26% down from last year.
  • Biofrontera's Short term Debt amounted to $296000.0 in Q2 2024.
  • Over the past 5 years, Biofrontera's Short term Debt peaked at $7.2 million during Q3 2023, and registered a low of $296000.0 during Q2 2024.
  • In the last 4 years, Biofrontera's Short term Debt had a median value of $3.6 million in 2021 and averaged $4.3 million.
  • In the last 5 years, Biofrontera's Short term Debt skyrocketed by 12242.44% in 2023 and then plummeted by 6651.02% in 2024.
  • Quarter analysis of 4 years shows Biofrontera's Short term Debt stood at $3.2 million in 2021, then skyrocketed by 114.13% to $6.9 million in 2022, then tumbled by 43.76% to $3.9 million in 2023, then plummeted by 92.42% to $296000.0 in 2024.
  • Its Short term Debt was $296000.0 in Q2 2024, compared to $2.4 million in Q1 2024 and $3.9 million in Q4 2023.